B. Belandia

发表

Nuclear receptor regulation gears up another Notch

M. Parker, B. Belandia, Borja Belandia, 2006, Nuclear receptor signaling.

Blockage of autophagic flux is associated with lymphocytosis and higher percentage of tumoral cells in chronic lymphocytic leukemia of B cells

R. Sánchez-Prieto, F. Ruiz-Marcos, M. Ruiz-Hidalgo, 2019, Clinical and Translational Oncology.

Identification and characterization of novel potentially oncogenic mutations in the human BAF57 gene in a breast cancer patient

E. Espinosa, Juan Ángel Fresno Vara, M. Villaronga, 2011, Breast Cancer Research and Treatment.

ERK5 Is a Major Determinant of Chemical Sarcomagenesis: Implications in Human Pathology

A. Esparís-Ogando, A. Pandiella, L. del Peso, 2022, Cancers.

Functional Interaction between the p160 Coactivator Proteins and the Transcriptional Enhancer Factor Family of Transcription Factors*

M. Parker, B. Belandia, Borja Belandia, 2000, The Journal of Biological Chemistry.

Thyroid Hormone Negatively Regulates the Transcriptional Activity of the β-Amyloid Precursor Protein Gene*

Á. Pascual, M. Latasa, A. Villa, 1998, The Journal of Biological Chemistry.

Attenuation of ribosomal protein S6 phosphatase activity in chicken embryo fibroblasts transformed by Rous sarcoma virus

J. Martín-Pérez, D. Brautigan, B. Belandia, 1994, Molecular and cellular biology.

Genetic perturbation of MAPK11 (p38 β ) promotes radiosensitivity by enhancing IR-associated senescence.

R. Sánchez-Prieto, S. Sabater, A. Rodríguez-González, 2022 .

p38β (MAPK11) mediates gemcitabine-associated radiosensitivity in sarcoma experimental models.

G. Bossi, R. Sánchez-Prieto, S. Sabater, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Thyroid Hormones Regulate β-Amyloid Gene Splicing and Protein Secretion in Neuroblastoma Cells.

Á. Pascual, M. Latasa, B. Belandia, 1998, Endocrinology.

Thyroid hormones regulate beta-amyloid gene splicing and protein secretion in neuroblastoma cells.

Á. Pascual, M. Latasa, B. Belandia, 1998, Endocrinology.

Control of S6 phosphorylation in normal and v-src transformed cells

J. Martín-Pérez, M. Carretero, B. Belandia, 1993 .

P53 pathway is a major determinant in the radiosensitizing effect of Palbociclib: Implication in cancer therapy.

R. Sánchez-Prieto, S. Sabater, M. Ruiz-Hidalgo, 2019, Cancer letters.

A response unit in the first exon of the beta-amyloid precursor protein gene containing thyroid hormone receptor and Sp1 binding sites mediates negative regulation by 3,5,3'-triiodothyronine.

Á. Pascual, A. Villa, B. Belandia, 2004, Molecular endocrinology.

Targeting of SWI/SNF chromatin remodelling complexes to estrogen‐responsive genes

H. Hurst, R. Orford, B. Belandia, 2002, The EMBO journal.

Nuclear Receptors A Rendezvous for Chromatin Remodeling Factors

M. Parker, B. Belandia, 2003, Cell.

HEY1 functions are regulated by its phosphorylation at Ser-68

E. Calvo, J. López, A. Arruabarrena-Aristorena, 2016, Bioscience reports.

Repression of Androgen Receptor Activity by HEYL, a Third Member of the Hairy/Enhancer-of-split-related Family of Notch Effectors*

M. Walker, M. Villaronga, Anup Patel, 2011, The Journal of Biological Chemistry.

ERK5 signalling pathway is a novel target of sorafenib: Implication in EGF biology

J. Encinar, R. Sánchez-Prieto, I. Sánchez-Pérez, 2021, Journal of cellular and molecular medicine.

Notch signaling: a potential therapeutic target in prostate cancer.

M. Villaronga, C. Bevan, B. Belandia, 2008, Current cancer drug targets.

Hey1, a Mediator of Notch Signaling, Is an Androgen Receptor Corepressor

M. Walker, M. Parker, J. García-Pedrero, 2005, Molecular and Cellular Biology.

HEY1 Leu94Met gene polymorphism dramatically modifies its biological functions

S. Llanos, M. Villaronga, C. Bevan, 2010, Oncogene.

The SWI/SNF Chromatin Remodeling Subunit BAF57 Is a Critical Regulator of Estrogen Receptor Function in Breast Cancer Cells*

E. Kiskinis, M. Parker, J. García-Pedrero, 2006, Journal of Biological Chemistry.

The transcription factor CREBZF is a novel positive regulator of p53

S. Llanos, M. Villaronga, B. Belandia, 2012, Cell cycle.

P38 MAPK and Radiotherapy: Foes or Friends?

R. Sánchez-Prieto, S. Sabater, M. Ruiz-Hidalgo, 2023, Cancers.

Mechanisms of androgen receptor repression in prostate cancer.

S. Gamble, C. Bevan, G. Brooke, 2006, Biochemical Society transactions.

Autophagic cell death associated to Sorafenib in renal cell carcinoma is mediated through Akt inhibition in an ERK1/2 independent fashion

R. Sánchez-Prieto, J. M. Giménez-Bachs, M. Ruiz-Hidalgo, 2018, PloS one.

Identification of BAF57 mutations in human breast cancer cell lines

E. Kiskinis, M. Parker, J. García-Pedrero, 2006, Breast Cancer Research and Treatment.

MAPK11 (p38β) is a major determinant of cellular radiosensitivity by enhancing IR-associated senescence

R. Sánchez-Prieto, S. Sabater, A. Rodríguez-González, 2023, bioRxiv.

eIF2 kinases mediate β-lapachone toxicity in yeast and human cancer cells

J. Murguía, J. Gadea, M. Menacho-Márquez, 2015, Cell cycle.

MAPK11 (p38β) is a major determinant of cellular radiosensitivity by controlling ionizing radiation-associated senescence: An in vitro study

R. Sánchez-Prieto, S. Sabater, M. Ruiz-Hidalgo, 2023, Clinical and translational radiation oncology.